Carey Robyn M, Balcz Brigitte A, Lopez-Coviella Ignacio, Slack Barbara E
Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
BMC Cell Biol. 2005 Aug 11;6:30. doi: 10.1186/1471-2121-6-30.
The amyloid precursor protein (APP) is transported via the secretory pathway to the cell surface, where it may be cleaved within its ectodomain by alpha-secretase, or internalized within clathrin-coated vesicles. An alternative proteolytic pathway occurs within the endocytic compartment, where the sequential action of beta- and gamma-secretases generates the amyloid beta protein (Abeta). In this study, we investigated the effects of modulators of endocytosis on APP processing.
Human embryonic kidney cells were transfected with a dominant negative mutant of dynamin I, an important mediator of clathrin-dependent endocytosis, and APP proteolysis was analyzed. Overexpression of the mutant dynamin (dyn I K44A) resulted in increased shedding of the APP ectodomain (sAPPalpha), accumulation of the C-terminal alpha-secretase product C83, and a reduction in the release of Abeta. Levels of mature APP on the cell surface were increased in cells expressing dyn I K44A, and internalization of surface-immunolabeled APP, assessed by fluorescence microscopy, was inhibited. Dynamin is a substrate for protein kinase C (PKC), and it was hypothesized that activators of PKC, which are known to stimulate alpha-secretase-mediated cleavage of APP, might exert their effects by inhibiting dynamin-dependent endocytosis. However, the internalization of surface-biotinylated APP was unaffected by treatment of cells with phorbol 12-myristate 13-acetate in the presence of the alpha-secretase inhibitor TAPI-1.
The results indicate that APP is internalized by a dynamin-dependent process, and suggest that alterations in the activity of proteins that mediate endocytosis might lead to significant changes in Abeta production.
淀粉样前体蛋白(APP)通过分泌途径转运至细胞表面,在细胞表面其胞外结构域可被α-分泌酶切割,或在内陷素包被的小泡内内化。另一种蛋白水解途径发生在内吞区室,β-和γ-分泌酶的相继作用产生淀粉样β蛋白(Aβ)。在本研究中,我们研究了内吞调节剂对APP加工的影响。
用发动蛋白I的显性负突变体转染人胚肾细胞,发动蛋白I是网格蛋白依赖性内吞作用的重要介质,并分析APP的蛋白水解。突变型发动蛋白(dyn I K44A)的过表达导致APP胞外结构域(sAPPα)的脱落增加、C末端α-分泌酶产物C83的积累以及Aβ释放减少。在表达dyn I K44A的细胞中,细胞表面成熟APP的水平增加,通过荧光显微镜评估,表面免疫标记的APP的内化受到抑制。发动蛋白是蛋白激酶C(PKC)的底物,据推测,已知刺激APP的α-分泌酶介导切割的PKC激活剂可能通过抑制发动蛋白依赖性内吞作用发挥其作用。然而,在存在α-分泌酶抑制剂TAPI-1的情况下,用佛波醇12-肉豆蔻酸酯13-乙酸酯处理细胞,表面生物素化的APP的内化不受影响。
结果表明APP通过发动蛋白依赖性过程内化,并提示介导内吞作用的蛋白质活性改变可能导致Aβ产生的显著变化。